Real‐world efficacy and safety outcomes of imatinib treatment in patients with chronic myeloid leukemia: An Australian experience-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real‐world efficacy and safety outcomes of imatinib treatment in patients with chronic myeloid leukemia: An Australian experience

Published:2022-09-14 Issue:5 Volume:10 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacology Res & Perspec

Author:

Adattini Josephine A.¹^ORCID,Gross Annette S.¹²^ORCID,Wong Doo Nicole³^ORCID,McLachlan Andrew J.¹^ORCID

Affiliation:

1. Sydney Pharmacy School The University of Sydney Sydney New South Wales Australia

2. Clinical Pharmacology Modelling & Simulation GlaxoSmithKline R &D Sydney New South Wales Australia

3. Concord Cancer Centre Concord Repatriation General Hospital Sydney New South Wales Australia

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.1005

Reference126 articles.

1. Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

2. First-line imatinib vs second- and third-generation TKIs for chronic-phase CML: a systematic review and meta-analysis

3. Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

4. International Randomized Study of Interferon Vs STI571 (IRIS) 8-Year Follow up: Sustained Survival and Low Risk for Progression or Events in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Imatinib.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imatinib-induced ulcerative colitis;Journal of Oncology Pharmacy Practice;2024-05-21

2. Application of physiologically based pharmacokinetic modeling to understand real‐world outcomes in patients receiving imatinib for chronic myeloid leukemia;Pharmacology Research & Perspectives;2023-07-07

3. Insights into dasatinib use and outcomes in real-world patients with chronic myeloid leukemia;Haematologica;2023-01-19

4. Bayesian analysis of the effect of exosomes in a mouse xenograft model of chronic myeloid leukemia;Mathematical Biosciences and Engineering;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3